Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SmithKline Beecham's Lyme disease vaccine recommended for FDA approval

May 27, 1998

La Jolla Pharmaceutical develops commercial-scale process for LJP-394

May 27, 1998

Hyaluronate effective in preventing rejection in rat kidney allograft model

May 26, 1998

Pharmacokinetics and safety of SDZ-RAD reported at transplant meeting

May 25, 1998

Cystic fibrosis gene also protects against typhoid fever

May 25, 1998

Improved immunosuppression and synergistic effects described for malononitrilamides

May 22, 1998

Nicaraven shows promise for protecting liver transplants

May 22, 1998

Safety profile of ISIS-2302 in renal transplant patients

May 22, 1998

Results from phase II trial of Campylobacter vaccine

May 22, 1998

Icos begins phase I/II trial for antipsoriatic

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...